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Fragmentation of the actin binding glycolytic enzyme, aldolase, with cyanogen bromide yields an 18K actin binding fragment which corresponds 
to residues l-164 of the aldolase sequence. Wtthin this fragment there is a region of sequence (residues 32-52) which IS htghly homologous to a 
region of sequence near the C-terminus of actin itself and which 1s also found in the actin bindmg domains of a number of other actin bmding 
proteins. A synthetic pepttde corresponding to the aldolase sequence 32-52 encompassmg this region of homology binds to F-actin and specifically 
competes with native aldolase for binding to this cytoskeletal protein. 
Aldolase, Actin: Actin binding peptide 
1. INTRODUCTION 
For many years now it has been known that the gly- 
colytic enzyme aldolase can interact with F-actin. In 
fact, aldolase was one of the first actin binding proteins 
to be described when it was found to be localised within 
the I-band of skeletal muscle myofibrils and to associate 
with F-actin in vitro [1,2]. Further in vitro studies have 
revealed that aldolase is capable of interacting with F- 
actin under physiological conditions and that the al- 
dolase/actin association affects not only the kinetics of 
the enzyme and its ability to interact with other enzymes 
but also it can influence the structural organisation of 
the actin filaments themselves [3-61. Electron micros- 
copy and other physical studies have shown that al- 
dolase is capable of organising actin filaments into 
highly ordered three-dimensional structures indicating 
that the enzyme/actin interaction may have a functional 
duality, one catalytic and the other structural [7]. Re- 
cently, microinjection studies of fluorescent labelled al- 
dolase into living cells have revealed that aldolase is 
associated with actin in vivo, attesting to the physiolog- 
ical relevance of this interaction [8,9]. However, no mo- 
lecular details of the aldolasejactin interaction site(s) 
have yet been determined. There have been numerous 
reports [ 1 O-1 21 identifying the interaction sites between 
actin and a variety of other actin binding proteins and 
in many of these studies the basic experimental ap- 
proach has involved chemical or proteolytic cleavage of 
the binding protein with subsequent screening of the 
resultant peptides for their ability to interact with F- 
actin. Using a similar approach, we have identified an 
actin binding region within the aldolase molecule which 
contains a section of sequence homologous with a re- 
gion at the C-terminus of actin itself [13]. 
2. MATERIALS AND METHODS 
2.1. Preparatron of aldoluse peptldes 
Aldolase from rabbit skeletal muscle was purchased from Boeh- 
ringer-Mannheim GmbH and rt was reduced, carboxymethylated and 
fragmented with cyanogen bromide and the peptides were separated 
using gel permeatron chromatography on Sephadex G-75 as described 
by Freemont et al [14]. The Isolated peptides were designated 25K 
(l-232) 18K (l-164) 7K(165_232),2K(2333250)and 13K(251-363). 
A synthetic pepttde with the sequence ADESTGSIAKRL- 
QSIGTENTE corresponding to the rabbit muscle aldolase sequence 
residues 32-52 was synthestsed usmg an Applied Biosystems Peptide 
Synthestser at the Queensland Protein and Nucleic Acid Research 
Centre. After cleavage from the resm the peptide was purified by 
reverse phase HPLC on a Cl8 column (Spherisorb ODSZ; 250 x 10 
mm) usmg a linear gradient of O&60% acetonitrile in 0.1% trifluoroa- 
cetrc acid over 55 mm. For use m the binding studies. peptide was 
lyophilised and resuspended in the appropriate buffer (see below). 
Peptides were quantified using a fluorescamine assay [15] with glycme 
as standard and by reference to the known lysine content of the 
pepttdes. 
2.2. Screening of peptide binding to F-actm 
To screen for binding to F-actin, samples of the cyanogen bromide 
peptides 2SK, 18K. 13K. 7K and 2K were incubated in the absence 
or the presence of 110 pg of F-actm in a final volume of 110 ~1 of 10 
mM PIPES, 40 mM KCl. 1 mM MgC12. 0.5 mM DTT, pH 6.8, in 
Beckman TL 100 ultracentrifuge tubes. After incubating at room 
temperature for one hour. 10 ~11 of each mixture was removed and 
retained. Samples were centrifuged at 80,000 rpm for 10 min and the 
supernatants were collected. The pellets were gently washed in the 
above buffer and then resuspended m 100 ~1 of 0.1 M sodium phos- 
phate buffer, pH 7.5, 1 mM EDTA, 1 mM DTT. Samples of the 
ortgmal mixture, supernatant and pellet were analysed by SDS-PAGE. 
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either 40 mM or 80 mM KCl, at pH 6.8 m Beckman TL 100 ultracen- 
trtfuge tubes. Increasing amounts of synthetic peptide were incubated 
with 400 pug of F-actin in the same buffer as above containing 40 mM 
KCl. Following centrifugation as described previously, the resulting 
supernatants were collected and analysed by reverse phase HPLC to 
quantitate the amount of free peptide present. Samples containing 
18K peptide were quantitated by analysis on a reverse phase C8 
column (Aquapore RP 300; 250 x 4.6 mm, Brownlee Labs) developed 
with a linear gradient from 30% acetonitrilelpropan-2-al/methanol 
(1:1:1) to 50% acetomtrile/propan-2-ol/methanol (l:l:l) over 10 min. 
The column was monitored at 215 and 280 nm usmg a Linear 206 PHD 
detector. Quantitation of the 18K peptide in each sample was achieved 
by measuring the area under the peak using an on line integrator (ICI 
DP800 data interface) and comparison of this with a standard curve 
established for the 18K peptide. Samples containing the synthetic 
peptide (aldolase 32-52) were similarly quantified by analysis on re- 
verse phase HPLC using a Cl8 column (Spherisorb 5s ODS-2: 
50 x 4.6 mm) developed with a linear gradient from 10% acetomtrile 
to 90% acetonitrile containmg 0.1% trtfluoroacetic acid over 10 min 
2.4. Competition between aldolase orp~~vate krnuse arld the synthetrc 
peptide for binding to F-arm 
1OOpg of F-actm was incubated with a fixed amount of aldolase (1.8 
PM) or pyruvate kinase (1.8 PM) in 10 mM PIPES, 40 mM KCl, 1 
mM MgC&, 0.5 mM DTT, pH 6.8. After a 1 h incubation at room 
temperature, all samples were centrifuged at 80,000 rpm for 10 mm 
and the supernatants discarded. Pellets were resuspended m 0.1 M 
sodium phosphate buffer, pH 7.5, 1 mM EDTA. 1 mM DTT and the 
amount of aldolase or pyruvate kinase present in the pellet fractions 
was quantitated by measuring the enzymatic activity. 
2.5. Other methods 
Rabbit skeletal muscle actm was prepared by the method of Spudich 
and Watt [16] except that a 0.8 M KC1 step was used. Aldolase and 
pyruvate kinase were assayed according to the procedure of Scopes 
[17] and SDS-PAGE was performed using 16% gels usmg the buffer 
system of Laemmli [18] and stained with Coomassie blue. 
3. RESULTS 
To screen for the ability of the aldolase cyanogen 
bromide derived peptids to interact with F-actin, sam- 
ples of each peptide were incubated in the presence and 
absence of actin, centrifuged and samples of the resul- 
tant supernatants and pellets, along with a sample of the 
original peptide/actin mixture were analysed on SDS- 
PAGE. Under the conditions studied the 13K, 7K and 
2K peptides did not interact with the F-actin; however, 
as shown in Fig. 1, the 18K peptide corresponding to 
residues l-164 of aldolase. clearly bound and sedi- 
mented with the F-actin. The 25K peptide was also 
capable of binding to F-actin but since this larger pep- 
tide contained the 18K peptide which was capable of 
binding F-actin, and the 7K peptide which was not, only 
the 18K peptide was investigated further. To further 
characterise this 18K peptide/actin association, a fixed 
amount of actin was incubated with increasing concen- 
trations of 18K peptide at two different ionic strengths. 
The samples were centrifuged and the resultant super- 
natants were analysed by reverse phase HPLC and the 
amount of peptide bound at each experimental point 
was calculated. Fig. 2 shows the binding isotherms ob- 
tained for 18K peptide binding to F-actin at 40 mM KC1 
70 
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Fig. 1. Co-sedimentation of F-actin and the aldolase 18K peptide. 
F-Actm was incubated with the aldolase 18K peptide and following 
centrifugation samples of the original mixture (M), supernatant (S) 
and the F-actin pellet (P) were analysed by SDS-PAGE with Coomas- 
ste blue staining. 
and 80 mM KCl. It can be seen that at 40 mM KC1 the 
18K peptide bound with a binding constant of approx- 
imately 1 x lo5 M-’ and reached a final stoichiometric 
ratio with respect to actin monomers of approximately 
1:2. At 80 mM KC1 the apparent affinity of binding was 
decreased a little (binding constant of approximately 
5 x lo4 M-‘) but peptide binding still reached the same 
stoichiometric ratio of 18K peptide:actin. 
Interestingly, as shown in Fig. 3, this region of the 
molecule (residues 1-l 64) contains a section of sequence 
(residues 3342) which is homologous not only to a 
region near the C-terminus of actin but also to sections 
of sequence found within the actin binding domains of 
a variety of other known actin binding proteins [13]. 
Consequently a synthetic peptide based on this region 
of homology and corresponding to residues 32-52 of the 
aldolase sequence was synthesised, purified and 
screened for its ability to interact with F-actin. Fig. 4 
illustrates the binding isotherm obtained when increas- 
ing concentrations of the synthetic peptide were incu- 
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Fig. 2. Bmdmg of the aldolase 18K peptide to 1OOpg of F-actin in 100 
~1 of 10 mM PIPES, 1 mM MgC12. 0 5 mM DTT. pH 6.8, contammg 
either 40 mM KC1 or 80 mM KCl. 
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Aldolase Dm 33 D E S G P T M G K R L Q D 45 Aldolase Dm 
Alcblase Rab.A 3 3 Aklolase RabA 
Aldolase Rat B 3 3 Aldolase Rat B 
Gelsolin 95 F T V Q L 108 Gelsolin 
Severin 98 Severin 
a -Actin 363 a -Actin 
Fig. 3 Amino acid sequence homology between aldolase and other actin binding proteins and the C-terminal end of actin. The boxes enclose regions 
of amino acid sequence homology with actin according to the following groups: S,T,G,A; I,V,M.P,L; H,R,K; D,E,Q,N; Y,W,F; C; Dm, Drosophila 
melanogaster; Rab. A, rabbit muscle aldolase A; Rat B. rat liver aldolase B. 
bated with F-actin. While the apparent affinity of bind- 
ing was much lower than that of the aldolase cyanogen 
bromide 18K peptide, it is clear that this synthetic pep- 
tide interacted with F-actin approaching an ultimate 
binding stoichiometric ratio of 1 peptide per actin mon- 
omer. Moreover, not only did this synthetic peptide 
bind to actin, it also specifically competed with native 
aldolase. When F-actin was incubated with a fixed 
amount of aldolase in the presence of increasing concen- 
trations of synthetic peptide and centrifuged, it was ob- 
served that with increasing synthetic peptide concentra- 
tion, there was a decrease in the amount of aldolase 
associated with the actin pellet (Fig. 5). However, the 
synthetic peptide was incapable of inhibiting the bind- 
ing of another glycolytic enzyme, pyruvate kinase, to 
F-actin (Fig. 5) indicating that the synthetic peptide 
corresponding to aldolase residues 32-52 specifically 
competed with native aldolase for binding to F-actin. 
4. DISCUSSION 
We have identified that one actin binding site on the 
aldolase molecule is located within residues 1-l 64. Con- 
tained within residues 1-164 of the aldolase polypeptide 
there exists a section of sequence between residues 33- 
42 which is homologous not only to sections of sequence 
within the actin binding domains of some other actin 
binding proteins such as gelsolin and severin (Fig. 3), 
but also to a region of sequence near the C-terminus of 
actin itself. The region of homology is based around the 
tetrapeptide sequence of ‘DESG’ or ‘DEAG’ to be 
found at positions 363-366 ofp- or a-actin, respectively. 
Within actin itself this ‘DE(S/A)G’ motif is believed to 
be located near an actin-actin interaction site involved 
in polymer formation as it has been shown that cysteine 
374 on one actin monomer can be crosslinked to lysine- 
191 on another actin monomer within the F-actin fila- 
ment [19,20]. The recent model of the F-actin filament 
proposed by Holmes et al. [21] indicates that these two 
residues are spatially close and in close proximity to an 
actin-actin interface. It has previously been proposed 
by Tellam et al. [13] that the actin binding properties of 
proteins such as gelsolin, severin, villin, etc., which pos- 
sess the ‘DE(S/A)G’ motif may in part be achieved by 
mimicry of actin-actin interaction sites. The present 
results indicate that aldolase may also fall into this cat- 
egory. 
The synthetic peptide corresponding to the region of 
aldolase which contains this sequence motif (aldolase 
32-52) was not only capable of binding to actin fila- 
ments. albeit with a lesser affinity than the native en- 
zyme, but also it was capable of specifically competing 
with aldolase for binding to actin filaments. Such obser- 
vations indicate that this smaller region within the al- 
dolase 18K peptide constitutes, or is at least part of, an 
actin binding site on this enzyme. This region is located 
on a small loop on the exterior surface of the aldolase 
subunit and it has been shown that the conformation of 
this region of the molecule is altered by the binding of 
substrate [22]. It has also been reported that fructose 
1,6_bisphosphate modifies aldolase binding to F-actin 
in vitro [7]. While not precluding the presence of other 
interaction sites elsewhere within the aldolase molecule, 
the present results would indicate the region identified 
above is involved in the interaction of this glycolytic 
enzyme with cytoskeletal actin. 
[Ald 32-521 mM 
Fig. 4. Bmdmg of aldolase synthetic peptide 32-52 to 100,ug of F-actm 
m 100,ui of 10 mM PIPES, 40 mM KCl, 1 mM MgCl?. 0.5 mM DTT, 
pH 6.8. 
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Fig. 5. Competition between aldolase synthetic peptide 32252 and 
aldolase or pyruvate kmase for binding to F-actin. The bindmg of 
aldolase (1.8 PM) and pyruvate kinase (1.8 PM) to 100 pg of F-actin 
was determined in the absence or presence of increasing concentra- 
tions of aldolase synthetic peptide 32252. 
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